Standex International (SXI) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
23 Dec, 2025Executive summary
Q3 FY25 sales rose 17.2% year-over-year to $207.8M, driven by acquisitions despite an 8.1% organic decline; highest sales since refrigeration business divestiture.
Record adjusted gross margin of 42.3% (up 230 bps YOY) and adjusted operating margin of 19.4% (up 280 bps YOY).
Fast growth end markets now 29% of total sales, with new product sales doubling YOY to $13.4M and contributing over 2% to top-line sales.
Major acquisitions included Amran/Narayan Group and McStarlite, with integration progressing well and expanding aerospace, space, and defense capabilities.
Free cash flow declined to $3.5M from $19.3M YOY due to higher capital expenditures and acquisition activity.
Financial highlights
Adjusted operating income up 37.3% YOY to $40.3M; adjusted EPS up 3.7% to $1.95; adjusted EBITDA rose 31.3% YOY to $45.3M.
Net income from continuing operations (GAAP) was $21.9M, up 37.6% YOY; adjusted net income was $23.5M, up 5.6% YOY.
Net cash from operations was $9.6M; capital expenditures $6.1M in Q3; FY25 capex expected between $25M and $30M.
Net debt at quarter-end was $470.4M, up sharply from $10.0M YOY, reflecting acquisition financing; leverage ratio at 2.8x.
Dividend per share increased 6.7% YOY to $0.32; 243rd consecutive quarterly dividend declared.
Outlook and guidance
Q4 FY25 expected to see slightly to moderately higher revenue and adjusted operating margin, driven by acquisitions, fast growth markets, and pricing initiatives.
Long-term targets for FY2028: sales >$1.15B, adjusted operating margin >23%, ROIC >15.5%, and fast growth market sales >$340M.
Organic growth expected to return in FY2026, especially in Electronics and Engineering Technologies.
Margin improvement in Q4 to be partially offset by higher tariff costs and increased investment in selling, marketing, and R&D.
Capital spending for FY25 projected at $25M–$35M; depreciation and amortization expected at $20–$22M and $12.5–$14.5M, respectively.
Latest events from Standex International
- Record profit, margin gains, and new launches set up >20% fast market growth for FY25.SXI
Q4 20242 Feb 2026 - Q2 FY26 delivered double-digit sales growth, margin expansion, and record order intake.SXI
Q2 20262 Feb 2026 - Record margin and a $462M acquisition set the stage for sequential growth.SXI
Q1 202518 Jan 2026 - Record sales and margins driven by acquisitions, but net income and cash flow declined.SXI
Q2 20259 Jan 2026 - Proxy covers director elections, pay, governance, risk, and ESG, with all proposals recommended.SXI
Proxy Filing1 Dec 2025 - Annual meeting covers director elections, incentive plan, pay, by-law, auditor, and ESG focus.SXI
Proxy Filing1 Dec 2025 - 2025 meeting covers director elections, say-on-pay, auditor ratification, and ESG priorities.SXI
Proxy Filing1 Dec 2025 - Shareholders will vote on a By-Law Amendment needing 80% approval, with Board support.SXI
Proxy Filing1 Dec 2025 - Record Q4 sales and margin expansion set up $100M+ revenue growth and new launches in FY26.SXI
Q4 202516 Nov 2025